NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
New Navy Platform Aims to Improve Medical Recordkeeping at Sea
The Operational Medical Care Delivery Platform captures patient care data aboard ships and integrates it with U.S.-based military medical networks.
4m read -
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch -
Marine Corps’ Project Dynamis Speeds AI for Future Battlefield Operations
Col. Arlon Smith shares how Project Dynamis is helping the Marine Corps rapidly field AI capabilities and operate in a future dominated by autonomous systems.
5m listen -
CMS Advances Zero Trust, AI Security in IT Modernization Push
The agency is consolidating platforms to improve security and efficiency.
10m watch
